PA8558601A1 - Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal - Google Patents
Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormalInfo
- Publication number
- PA8558601A1 PA8558601A1 PA20028558601A PA8558601A PA8558601A1 PA 8558601 A1 PA8558601 A1 PA 8558601A1 PA 20028558601 A PA20028558601 A PA 20028558601A PA 8558601 A PA8558601 A PA 8558601A PA 8558601 A1 PA8558601 A1 PA 8558601A1
- Authority
- PA
- Panama
- Prior art keywords
- procedures
- treatment
- cellular growth
- preparation
- abnormal cellular
- Prior art date
Links
- 230000002159 abnormal effect Effects 0.000 title abstract 2
- 230000010261 cell growth Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
LA INVENCION SE REFIERE A PROCEDIMIENTOS PARA PREPARAR COMPUESTOS DE FORMULA I Y A SALES, PROFARMACOS Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, EN LA QUE R1, R3, R4, R5, R11, M Y P SON COMO SE HAN DEFINIDO EN ESTE DOCUMENTO. LOS COMPUESTOS DE FORMULA I SON UTILES EN EL TRATAMIENTO DEL CRECIMIENTO CELULAR ANORMAL EN MAMIFEROS POR LA ADMINISTRACION DE COMPOSICIONES FARMACEUTICAS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33464701P | 2001-11-30 | 2001-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8558601A1 true PA8558601A1 (es) | 2003-06-30 |
Family
ID=23308141
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA20028558601A PA8558601A1 (es) | 2001-11-30 | 2002-11-25 | Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20030144506A1 (es) |
| EP (1) | EP1448551B1 (es) |
| JP (1) | JP4220388B2 (es) |
| KR (1) | KR20040054813A (es) |
| CN (1) | CN1639149A (es) |
| AR (1) | AR037591A1 (es) |
| AT (1) | ATE377009T1 (es) |
| AU (1) | AU2002337428A1 (es) |
| BR (1) | BR0214606A (es) |
| CA (1) | CA2462149C (es) |
| DE (1) | DE60223279T2 (es) |
| DO (1) | DOP2002000519A (es) |
| ES (1) | ES2295409T3 (es) |
| GT (1) | GT200200245A (es) |
| HN (1) | HN2002000334A (es) |
| HU (1) | HUP0500117A3 (es) |
| IL (1) | IL160971A0 (es) |
| MX (1) | MXPA04005157A (es) |
| PA (1) | PA8558601A1 (es) |
| PE (1) | PE20030643A1 (es) |
| PL (1) | PL370911A1 (es) |
| RS (1) | RS44004A (es) |
| RU (1) | RU2004116345A (es) |
| SV (1) | SV2004001419A (es) |
| TN (1) | TNSN02096A1 (es) |
| TW (1) | TW200300691A (es) |
| WO (1) | WO2003045939A1 (es) |
| ZA (1) | ZA200402054B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2005119172A (ru) * | 2002-12-18 | 2006-01-20 | Пфайзер Продактс Инк. (Us) | Производные 4-анилинхиназолина для лечения патологического роста клеток |
| KR20050085835A (ko) * | 2002-12-19 | 2005-08-29 | 화이자 프로덕츠 인코포레이티드 | Ｅ-2-메톡시-ｎ-（3-｛4-［3-메틸-4-（6-메틸-피리딘-3-일옥시）-페닐아미노］-퀴나졸린-6-일｝-알릴）-아세트아마이드의 착물, 및 그의 제조방법 및 용도 |
| RS20050652A (en) * | 2003-04-09 | 2007-11-15 | Pfizer Products Inc., | Process for the preparation of n- (((pyridinyloxy)- phenylamino)quinazolinyl)- alyl)acetamide derivatives and related compounds as well as intermediates of such processes and processes for the preparation of such intermediates |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| JP5129957B2 (ja) * | 2003-07-03 | 2013-01-30 | ミリアド ジェネティクス， インコーポレイテッド | カスパーゼの活性化因子およびアポトーシスの誘発因子としての４−アリールアミノ−キナゾリン |
| US20050192298A1 (en) * | 2004-02-27 | 2005-09-01 | Pfizer Inc | Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide |
| AU2005239878B9 (en) * | 2004-05-06 | 2010-01-07 | Warner-Lambert Company Llc | 4-phenylamino-quinazolin-6-yl-amides |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
| NZ569525A (en) * | 2005-12-02 | 2010-09-30 | Paper Products Ltd | Holographic flexible tube laminate for packaging and method of making the same |
| CN113382986A (zh) | 2018-09-25 | 2021-09-10 | 黑钻治疗公司 | 酪氨酸激酶抑制剂组合物、其制备方法和使用方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW321649B (es) * | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
| DE19501481A1 (de) * | 1995-01-19 | 1996-07-25 | Bayer Ag | 2,8-Disubstituierte Chinazolinone |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| CZ20023951A3 (cs) * | 2000-06-22 | 2004-01-14 | Pfizer Products Inc. | Substituované bicyklické deriváty pro léčení abnormálního buničného růstu |
-
2002
- 2002-10-03 KR KR10-2004-7008290A patent/KR20040054813A/ko not_active Application Discontinuation
- 2002-10-03 PL PL02370911A patent/PL370911A1/xx unknown
- 2002-10-03 AT AT02772689T patent/ATE377009T1/de not_active IP Right Cessation
- 2002-10-03 BR BR0214606-1A patent/BR0214606A/pt not_active IP Right Cessation
- 2002-10-03 MX MXPA04005157A patent/MXPA04005157A/es active IP Right Grant
- 2002-10-03 RU RU2004116345/04A patent/RU2004116345A/ru not_active Application Discontinuation
- 2002-10-03 WO PCT/IB2002/004097 patent/WO2003045939A1/en active IP Right Grant
- 2002-10-03 IL IL16097102A patent/IL160971A0/xx unknown
- 2002-10-03 HU HU0500117A patent/HUP0500117A3/hu unknown
- 2002-10-03 ES ES02772689T patent/ES2295409T3/es not_active Expired - Lifetime
- 2002-10-03 CN CNA028208994A patent/CN1639149A/zh active Pending
- 2002-10-03 JP JP2003547389A patent/JP4220388B2/ja not_active Expired - Fee Related
- 2002-10-03 RS YU44004A patent/RS44004A/sr unknown
- 2002-10-03 EP EP02772689A patent/EP1448551B1/en not_active Expired - Lifetime
- 2002-10-03 AU AU2002337428A patent/AU2002337428A1/en not_active Abandoned
- 2002-10-03 CA CA2462149A patent/CA2462149C/en not_active Expired - Fee Related
- 2002-10-03 DE DE60223279T patent/DE60223279T2/de not_active Expired - Lifetime
- 2002-11-21 DO DO2002000519A patent/DOP2002000519A/es unknown
- 2002-11-25 PE PE2002001129A patent/PE20030643A1/es not_active Application Discontinuation
- 2002-11-25 PA PA20028558601A patent/PA8558601A1/es unknown
- 2002-11-25 TW TW091134197A patent/TW200300691A/zh unknown
- 2002-11-27 HN HN2002000334A patent/HN2002000334A/es unknown
- 2002-11-28 AR ARP020104590A patent/AR037591A1/es unknown
- 2002-11-28 GT GT200200245A patent/GT200200245A/es unknown
- 2002-11-29 SV SV2002001419A patent/SV2004001419A/es not_active Application Discontinuation
- 2002-11-29 TN TNTNSN02096A patent/TNSN02096A1/en unknown
- 2002-12-02 US US10/307,603 patent/US20030144506A1/en not_active Abandoned
-
2004
- 2004-03-15 ZA ZA200402054A patent/ZA200402054B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0500117A3 (en) | 2008-03-28 |
| US20030144506A1 (en) | 2003-07-31 |
| IL160971A0 (en) | 2004-08-31 |
| EP1448551B1 (en) | 2007-10-31 |
| ATE377009T1 (de) | 2007-11-15 |
| PL370911A1 (en) | 2005-05-30 |
| PE20030643A1 (es) | 2003-07-23 |
| EP1448551A1 (en) | 2004-08-25 |
| RS44004A (en) | 2006-10-27 |
| ZA200402054B (en) | 2005-05-23 |
| WO2003045939A1 (en) | 2003-06-05 |
| AU2002337428A1 (en) | 2003-06-10 |
| TNSN02096A1 (en) | 2005-12-23 |
| CA2462149A1 (en) | 2003-06-05 |
| KR20040054813A (ko) | 2004-06-25 |
| JP2005515986A (ja) | 2005-06-02 |
| CA2462149C (en) | 2010-06-22 |
| DOP2002000519A (es) | 2003-05-31 |
| ES2295409T3 (es) | 2008-04-16 |
| BR0214606A (pt) | 2004-09-14 |
| GT200200245A (es) | 2003-09-24 |
| SV2004001419A (es) | 2004-02-24 |
| HN2002000334A (es) | 2003-02-21 |
| CN1639149A (zh) | 2005-07-13 |
| DE60223279D1 (de) | 2007-12-13 |
| MXPA04005157A (es) | 2004-08-11 |
| TW200300691A (en) | 2003-06-16 |
| DE60223279T2 (de) | 2008-05-29 |
| AR037591A1 (es) | 2004-11-17 |
| RU2004116345A (ru) | 2005-03-27 |
| HUP0500117A2 (hu) | 2005-05-30 |
| JP4220388B2 (ja) | 2009-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28135A1 (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
| ECSP024393A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal | |
| CY1118915T1 (el) | Αντιβακτηριακα αναλογα αμινογλυκοσιδης | |
| PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| CR20140368A (es) | Derivados y composiciones de isoindol 4´-0-sustituidos, composiciones que las comprenden y metodos de uso de los mismos (divisional 11036) | |
| PA8490601A1 (es) | Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos. | |
| ECSP088511A (es) | Agonistas del receptor del neuropeptido-2 | |
| PA8593001A1 (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
| CO4810375A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
| NI200700102A (es) | Derivados de indol tetraciclicos como agentes antiviricos | |
| UY32462A (es) | Derivados de bifenilo novedosos para el tratamiento de infección por virus de hepatitis c 644 | |
| PA8495101A1 (es) | Derivados de 13-metileritromicina | |
| TW200637817A (en) | 5-aminoindole derivatives | |
| PA8568101A1 (es) | Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso | |
| PA8558601A1 (es) | Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal | |
| BRPI0516381A (pt) | derivados de cromano e seu uso como ligandos de receptor de 5-ht | |
| UY27803A1 (es) | Derivados de benzoxazina y usos de los mismos. | |
| UY29134A1 (es) | Sulfonamidas sustituidas por derivados de bencimidazol, composiciones que la contienen, procedimiento de preparacion y aplicaciones | |
| TW200738697A (en) | Benzimidazole derivatives as 5-HT6,5-HT24 | |
| UY28357A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos | |
| CO4810376A1 (es) | Derivados de eritromicina triciclicos | |
| ATE465151T1 (de) | 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren | |
| PA8450901A1 (es) | Derivados de eritromicina | |
| ECSP024377A (es) | Derivados de benzo (g) quinolina | |
| PA8474401A1 (es) | 3-ceto derivados triciclicos de 6-0-metileritromicina |